2020 / 03 / 07
On March 6, on the sidelines of the 63rd session of the UN Commission on Narcotic Drugs, the SCO Secretary General Vladimir Norov met with Chairman of the International Narcotics Control Board Cornelis de Jonhere.
V. Norov informed the interlocutor about the activities of the SCO in the anti-drug direction, including the joint work of member states in the framework of a three-level mechanism for meetings of heads of competent authorities, the implementation of the SCO Anti-Drug Strategy for 2018-2023 and the Program of Action for its implementation, as well as the development of relations SCO Secretariat with UNODC and other international organizations. The Secretary-General noted that the Organization has an ad hoc working group of experts on precursors. In addition, he recalled the holding, with the assistance of the SCO Secretariat, of a profile expert meeting of the Paris Pact initiative in Shanghai in November 2019.
In turn, C. de Jonhere emphasized that INCB attaches great importance to cooperation with the SCO member states. He pointed out the urgency of the problem of the spread of synthetic drugs in the world and informed about the existing system of international monitoring of this process. The INCB Chairman also stated the need to monitor not only the leakage of the precursors themselves, but also the technical equipment used in the manufacturing process.
The meeting discussed prospects for developing contacts between the SCO Secretariat and the INCB, including through the participation of representatives of the two associations in relevant events.
An agreement was reached to maintain working contacts.
The International Narcotics Control Board (INCB) is a specialized agency of the UN system. Its composition, rights and obligations are determined by the relevant provisions of the Single Convention on Narcotic Drugs of 1961 and the Convention on Psychotropic Substances of 1971.
The main functions of the INCB are: monitoring the situation in the field of drug trafficking in order to maintain a balance between the production and consumption of drugs for medical and scientific purposes; preventing drug diversion into illicit traffic; control over the implementation by participating states of relevant international agreements; assisting countries and regions in solving problems related to drug control and combating their illicit trafficking.